540 related articles for article (PubMed ID: 23742830)
1. The significance of serum urokinase plasminogen activation receptor (suPAR) in the diagnosis and follow-up of febrile neutropenic patients with hematologic malignancies.
Kaya S; Köksal I; Menteşe A; Sönmez M; Sümer A; Yıldırım SS; Yılmaz G
Int J Infect Dis; 2013 Nov; 17(11):e1056-9. PubMed ID: 23742830
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic value of soluble urokinase plasminogen activator receptor compared with C-reactive protein and procalcitonin in children with febrile neutropenia.
Sirinoglu M; Soysal A; Karaaslan A; Kepenekli Kadayifci E; Cinel I; Koç A; Tokuç G; Yaman A; Haklar G; Şirikçi Ö; Turan S; Altınkanat Gelmez G; Söyletir G; Bakır M
Pediatr Hematol Oncol; 2016 Apr; 33(3):200-8. PubMed ID: 27057782
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic value of soluble urokinase plasminogen activator receptor (suPAR) compared to C-reactive protein (CRP) and procalcitonin (PCT) in children with systemic inflammatory response syndrome (SIRS).
Şirinoğlu M; Soysal A; Karaaslan A; Kepenekli Kadayifci E; Yalındağ-Öztürk N; Cinel İ; Yaman A; Haklar G; Şirikci Ö; Turan S; Altınkanat Gelmez G; Söyletir G; Bakır M
J Infect Chemother; 2017 Jan; 23(1):17-22. PubMed ID: 27771157
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndrome.
Hoenigl M; Raggam RB; Wagner J; Valentin T; Leitner E; Seeber K; Zollner-Schwetz I; Krammer W; Prüller F; Grisold AJ; Krause R
Clin Biochem; 2013 Feb; 46(3):225-9. PubMed ID: 23159293
[TBL] [Abstract][Full Text] [Related]
5. Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome.
Raggam RB; Wagner J; Prüller F; Grisold A; Leitner E; Zollner-Schwetz I; Valentin T; Krause R; Hoenigl M
J Intern Med; 2014 Dec; 276(6):651-8. PubMed ID: 24645798
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis.
Zeng M; Chang M; Zheng H; Li B; Chen Y; He W; Huang C
Am J Emerg Med; 2016 Mar; 34(3):375-80. PubMed ID: 26615223
[TBL] [Abstract][Full Text] [Related]
7. Elevated procalcitonin predicts Gram-negative sepsis in haematological patients with febrile neutropenia.
Koivula I; Hämäläinen S; Jantunen E; Pulkki K; Kuittinen T; Nousiainen T; Juutilainen A
Scand J Infect Dis; 2011 Jul; 43(6-7):471-8. PubMed ID: 21299364
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in systemic inflammatory response syndrome.
Yilmaz G; Köksal I; Karahan SC; Mentese A
Clin Biochem; 2011 Oct; 44(14-15):1227-30. PubMed ID: 21816136
[TBL] [Abstract][Full Text] [Related]
9. Comparison of soluble urokinase plasminogen activator receptor, soluble triggering receptor expressed on myeloid cells 1, procalcitonin and C-reactive protein in distinguishing concurrent bacterial infection from idiopathic inflammatory myopathy.
Xiao Y; Luo H; Zhou B; Dai X; Huang J; Duan L; You Y; Zhang W; Zhao H; Xie Y; Zhou Y; Ning W; Li T; Liu S; Zhu H; Xie X; Jiang Y; Wu S; He W; Li Y
Rheumatol Int; 2017 Apr; 37(4):585-592. PubMed ID: 27878344
[TBL] [Abstract][Full Text] [Related]
10. Soluble triggering receptor expressed on myeloid cells-1 as an infection marker for patients with neutropenic fever.
Lin CH; Yao M; Hsu SC; Ho CC; Lin MT; Lin CA; Hu FC; Yu CJ; Tien HF
Crit Care Med; 2011 May; 39(5):993-9. PubMed ID: 21283000
[TBL] [Abstract][Full Text] [Related]
11. Soluble form of urokinase-type plasminogen activator receptor as a diagnostic and prognostic marker in hematological patients with neutropenic fever.
Vänskä M; Purhonen AK; Koivula I; Jantunen E; Hämäläinen S; Pulkki K; Juutilainen A
Leuk Lymphoma; 2014 Mar; 55(3):718-21. PubMed ID: 23734690
[No Abstract] [Full Text] [Related]
12. Early Changes of Mannose-Binding Lectin, H-Ficolin, and Procalcitonin in Patients with Febrile Neutropenia: A Prospective Observational Study.
Işlak Mutcalı S; Saltoğlu N; Balkan İİ; Özaras R; Yemişen M; Tabak F; Mert A; Öztürk R; Öngören Ş; Başlar Z; Aydın Y; Ferhanoğlu B; Soysal T
Turk J Haematol; 2016 Dec; 33(4):304-310. PubMed ID: 26377840
[TBL] [Abstract][Full Text] [Related]
13. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.
von Lilienfeld-Toal M; Dietrich MP; Glasmacher A; Lehmann L; Breig P; Hahn C; Schmidt-Wolf IG; Marklein G; Schroeder S; Stuber F
Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):539-44. PubMed ID: 15221617
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia.
Erkut N; Menteşe A; Özbaş HM; Ermantaş N; Sümer A; Örem A; Sönmez M
Turk J Haematol; 2016 Jun; 33(2):135-40. PubMed ID: 26376588
[TBL] [Abstract][Full Text] [Related]
15. [Application value of procalcitonin and immune inflammatory factors for prediction of bacteraemia in patients with hematologic malignancy combined with febrile neutropenia].
Fu Y; Jiang H; Li LX; Chen J; Zhang JL; Wang LL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1296-300. PubMed ID: 24156453
[TBL] [Abstract][Full Text] [Related]
16. The predictive and diagnostic values of procalcitonin and C-reactive protein for clinical outcome in febrile neutropenic patients.
Erten N; Genc S; Besisik SK; Saka B; Karan MA; Tascioglu C
J Chin Med Assoc; 2004 May; 67(5):217-21. PubMed ID: 15357107
[TBL] [Abstract][Full Text] [Related]
17. Soluble urokinase plasminogen activator receptor: an indicator of pneumonia severity in children.
Wrotek A; Jackowska T; Pawlik K
Adv Exp Med Biol; 2015; 835():1-7. PubMed ID: 25315615
[TBL] [Abstract][Full Text] [Related]
18. Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis.
Zimmermann HW; Koch A; Seidler S; Trautwein C; Tacke F
Liver Int; 2012 Mar; 32(3):500-9. PubMed ID: 22098627
[TBL] [Abstract][Full Text] [Related]
19. Soluble urokinase-type plasminogen activator receptor in patients with suspected infection in the emergency room: a prospective cohort study.
Uusitalo-Seppälä R; Huttunen R; Tarkka M; Aittoniemi J; Koskinen P; Leino A; Vahlberg T; Rintala EM
J Intern Med; 2012 Sep; 272(3):247-56. PubMed ID: 22755554
[TBL] [Abstract][Full Text] [Related]
20. Soluble urokinase plasminogen activator receptor (suPAR) for assessment of disease severity in ventilator-associated pneumonia and sepsis.
Savva A; Raftogiannis M; Baziaka F; Routsi C; Antonopoulou A; Koutoukas P; Tsaganos T; Kotanidou A; Apostolidou E; Giamarellos-Bourboulis EJ; Dimopoulos G
J Infect; 2011 Nov; 63(5):344-50. PubMed ID: 21839112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
